RT Journal Article
SR Electronic
T1 Viral and host factors associated with SARS-CoV-2 disease severity in Georgia, USA
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.10.25.23297530
DO 10.1101/2023.10.25.23297530
A1 Carmola, Ludy R.
A1 Roebling, Allison Dorothy
A1 Khosravi, Dara
A1 Langsjoen, Rose M.
A1 Bombin, Andrei
A1 Bixler, Bri
A1 Reid, Alex
A1 Chen, Cara
A1 Wang, Ethan
A1 Lu, Yang
A1 Zheng, Ziduo
A1 Zhang, Rebecca
A1 Nguyen, Phuong-Vi
A1 Arthur, Robert A.
A1 Fitts, Eric
A1 Gulick, Dalia Arafat
A1 Higginbotham, Dustin
A1 Taz, Azmain
A1 Ahmed, Alaa
A1 Crumpler, John Hunter
A1 Kraft, Colleen
A1 Lam, Wilbur A.
A1 Babiker, Ahmed
A1 Waggoner, Jesse J.
A1 Openo, Kyle P.
A1 Johnson, Laura M.
A1 Westbrook, Adrianna
A1 Piantadosi, Anne
YR 2023
UL http://medrxiv.org/content/early/2023/10/25/2023.10.25.23297530.abstract
AB While SARS-CoV-2 vaccines have shown strong efficacy, their suboptimal uptake combined with the continued emergence of new viral variants raises concerns about the ongoing and future public health impact of COVID-19. We investigated viral and host factors, including vaccination status, that were associated with SARS-CoV-2 disease severity in a setting with low vaccination rates. We analyzed clinical and demographic data from 1,957 individuals in the state of Georgia, USA, coupled with viral genome sequencing from 1,185 samples. We found no difference in disease severity between individuals infected with Delta and Omicron variants among the participants in this study, after controlling for other factors, and we found no specific mutations associated with disease severity. Compared to those who were unvaccinated, vaccinated individuals experienced less severe SARS-CoV-2 disease, and the effect was similar for both variants. Vaccination within 270 days before infection was associated with decreased odds of moderate and severe outcomes, with the strongest association observed at 91-270 days post-vaccination. Older age and underlying health conditions, especially immunosuppression and renal disease, were associated with increased disease severity. Overall, this study provides insights into the impact of vaccination status, variants/mutations, and clinical factors on disease severity in SARS-CoV-2 infection when vaccination rates are low. Understanding these associations will help refine and reinforce messaging around the crucial importance of vaccination in mitigating the severity of SARS-CoV-2 disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementYesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the institutional review board at Emory University under protocol STUDY00000260.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes